Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function-Reference-Cited by-同舟云学术

Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function

Published:2021-01-19 Issue:6 Volume:109 Page:1593-1605
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Limdi Nita A.¹,Beasley Timothy Mark²,Sun Jielin³,Stockbridge Norman⁴,Pacanowski Michael³,Florian Jeffry³

Affiliation:

1. Department of Neurology University of Alabama at Birmingham Birmingham Alabama USA

2. Department of Biostatistics University of Alabama at Birmingham Birmingham Alabama USA

3. Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

4. Division of Cardiovascular and Renal Products Office of New Drugs I Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2131

Reference53 articles.

1. Chronic kidney disease

2. Prevalence of Chronic Kidney Disease in the United States

3. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease